Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Oncopeptides Debt to Equity Ratio: 0.8095 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.8095 |
| June 30, 2023 | 0.6164 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
0.8095
Maximum
Sep 2023
0.1296
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Abliva AB | -- |
| BioInvent International AB | 0.00 |
| Hansa Biopharma AB | -2.947 |
| BioArctic AB | 0.00 |
| Camurus AB | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 27.02M |
| Total Liabilities (Quarterly) | 14.80M |
| Shareholders Equity (Quarterly) | 12.22M |
| Current Ratio | 6.678 |
| Net Debt Paydown Yield | -2.57% |